17 studies found for:    lorcaserin [TREATMENT] AND obesity [DISEASE]
Show Display Options
Rank Status Study
1 Recruiting Lorcaserin in Obesity: Identification of CNS Targets Using fMRI
Conditions: Obesity;   Weight Loss
Interventions: Drug: Lorcaserin HCl;   Drug: Placebo
2 Completed
Has Results
BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity Management
Condition: Obesity
Interventions: Drug: Lorcaserin 10 mg QD;   Drug: Lorcaserin 10 mg BID;   Drug: Matching Placebo
3 Completed
Has Results
BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management
Condition: Obesity
Interventions: Drug: Lorcaserin 10 mg BID;   Drug: Matching Placebo BID
4 Completed
Has Results
BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus
Condition: Obesity
Interventions: Drug: Lorcaserin 10 mg QD;   Drug: Lorcaserin 10 mg BID;   Drug: Matching Placebo
5 Not yet recruiting A Single Dose Pharmacokinetic Study of Lorcaserin Hydrochloride in Obese Pediatric Subjects 6 to 11 Years of Age
Condition: Obesity
Intervention: Drug: Lorcaserin hydrochloride
6 Recruiting A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
Conditions: Cardiovascular Disease;   High Cardiovascular Risk;   Obesity;   Overweight;   Type 2 Diabetes
Interventions: Drug: APD356-Lorcaserin hydrochloride;   Drug: Placebo
7 Completed Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly Subjects
Condition: Obesity
Intervention: Drug: lorcaserin
8 Completed Safety and Efficacy of APD356 in the Treatment of Obesity
Condition: Obesity
Intervention: Drug: APD356
9 Completed Safety and Efficacy of APD356 in the Treatment of Obesity
Condition: Obesity
Intervention: Drug: APD356
10 Active, not recruiting Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management
Conditions: Overweight;   Obese
Interventions: Device: LLLT;   Drug: Lorcaserin
11 Completed Single Dose Study to Determine the Safety, Tolerability, and Pharmacokinetic Properties of Lorcaserin Hydrochloride (BELVIQ) in Obese Adolescents From 12 to 17 Years of Age
Condition: Pharmacokinetics in Obese Adolescents
Intervention: Drug: Lorcaserin
12 Completed To Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food Intake
Condition: Obesity
Interventions: Drug: Placebo;   Drug: Lorcaserin 10mg BID
13 Not yet recruiting Varenicline and Lorcaserin for Post Cessation Weight Gain
Conditions: Obesity;   Smoking Cessation
Interventions: Drug: lorcaserin;   Drug: Varenicline;   Drug: Placebo
14 Recruiting Lifestyle Modification and Lorcaserin for Weight Loss Maintenance
Condition: Obesity
Interventions: Drug: Lorcaserin;   Drug: Placebo
15 Completed Pharmacokinetic Properties of Lorcaserin in the Fed and Fasted State
Condition: Obesity
Intervention: Drug: Lorcaserin 10mg
16 Completed A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults
Condition: Chronic Weight Management
Interventions: Drug: lorcaserin + phentermine placebo;   Drug: lorcaserin + phentermine-HCl + phentermine placebo;   Drug: lorcaserin + phentermine-HCl
17 Completed Lorcaserin for Preventing Weight Gain Among Smokers
Conditions: Tobacco Use Disorder;   Weight Gain
Interventions: Drug: Varenicline;   Drug: Lorcaserin

Indicates status has not been verified in more than two years